Table 2. Distribution of efflux genes among clinical and non-clinical enterococcus isolates according to antimicrobial resistance pattern.
Number of isolates | Antibiotic resistance | Biocide reduced susceptibility | Efflux pump genes | |
---|---|---|---|---|
Clinical | ||||
11 | CIP, GEN | CHX | efrA, efrB, emeA | |
1 | CIP, GEN | CHX | efrA, efrB | |
3 | - | CHX | efrA, efrB, emeA | |
1 | - | CHX | efrA, efrB | |
2 | GEN | - | efrA, efrB, emeA | |
1 | GEN | - | efrA, efrB | |
3 | CIP, GEN | BCC | efrA, efrB, emeA | |
1 | CIP | - | efrA, efrB, emeA | |
2 | VAN, CIP, GEN | CHX, BCC | efrA, efrB, emeA | |
2 | VAN, CIP, GEN | CHX, BCC | - | |
1 | VAN, CIP | - | efrA, efrB, emeA | |
1 | VAN, CIP | CHX, BCC | - | |
8 | VAN, CIP, GEN | - | - | |
1 | VAN, CIP, GEN | BCC | efrA, efrB | |
1 | CIP, GEN | - | efrA, efrB, emeA | |
1 | GM | CHX | - | |
1 | GM | CHX | efrA, efrB, emeA | |
1 | VAN, GEN | CHX | efrA, efrB, emeA | |
1 | GM | CHX, BCC | efrA, efrB, emeA | |
1 | CIP | CHX | efrA, efrB, emeA | |
1 | CIP | CHX | - | |
1 | CIP, GEN | CHX, BCC | - | |
1 | CIP, GEN | CHX | - | |
1 | CIP, GEN | - | - | |
1 | - | CHX, BCC | efrA, efrB | |
3 | VAN | CHX | efrA, efrB, emeA | |
2 | CIP, GEN | BCC | - | |
Non-clinical | ||||
2 | CIP, GEN | CHX | efrA, efrB | |
5 | - | CHX | efrA, efrB, emeA | |
2 | GEN | CHX | efrA, efrB, emeA | |
2 | CIP, GEN | CHX | efrA, efrB, emeA | |
1 | - | CHX | efrA, efrB | |
1 | CIP | CHX, BCC | efrA, efrB | |
2 | CIP | - | efrA, efrB, emeA | |
1 | GEN | BCC | efrA, efrB, emeA | |
2 | - | BCC | efrA, efrB, emeA | |
1 | - | CHX, BCC | efrA, efrB, emeA | |
1 | - | - | efrA, efrB, emeA | |
5 | - | BCC | - | |
13 | CIP | BCC | - | |
1 | VAN, CIP, GEN | CHX, BCC | - | |
1 | - | CHX, BCC | - | |
2 | CIP | CHX | - | |
1 | - | CHX | - | |
2 | CIP | - | - | |
1 | CIP, GEN | CHX, BCC | - | |
4 | - | - | - |
CIP, ciprofloxacin; GEN, gentamicin; CHX, chlorhexidine gluconate; VAN, vancomycin; BCC, benzalkonium chloride.